TVM Capital Healthcare has announced the first closing of its $150m TVM Healthcare Southeast Asia Fund, aimed at expanding healthcare access in the region. The fund will focus on high-demand areas such as post-acute care, women’s health, and local pharmaceutical manufacturing, addressing gaps in the market.
The fund’s commitments come from a diverse group of institutional investors, including cornerstone investor Invest International, which is backed by the Dutch government and FMO. This strategic partnership aims to drive sustainable economic growth and create positive social impact.
Hoda Abou-Jamra, Co-Founder and Managing Partner of Southeast Asia at TVM Capital Healthcare, emphasised the fund’s role in supporting the region’s healthcare ecosystem. “By combining capital with operational expertise and introducing proven healthcare models from around the world, we are helping to create companies that can lead nationally and regionally,” she said.
The fund will also invest in healthcare innovators from the US and Europe, facilitating their expansion into Southeast Asia. This includes building partnerships with US-based, Harvard-affiliated teaching hospitals and leading European medtech companies to transfer advanced medical technologies and best practices.
Jannie Tsuei, Partner at TVM Capital Healthcare, highlighted the unique opportunities in Southeast Asia’s healthcare sector. “With our investment strategy that combines local growth with international expansion, we can help companies scale into institutional-quality leaders delivering impactful healthcare outcomes,” Tsuei noted.
The initiative underscores the resilience of healthcare as an investment sector and its critical role in economic and social development. As the fund progresses, it aims to build healthcare infrastructure that benefits patients and supports long-term development in Southeast Asia.
“`
